ARAY vs TECH · rev $458.5M vs P/E 65, rev $1.22B
Accuray Incorporated (ARAY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Accuray Incorporated (ARAY) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ARAY revenue for 2025-06-30 was $458.5M. Net income was -$1.6M. Revenue was up 2.7% from 2024-06-30 to 2025-06-30. ARAY currently screens at market cap $140.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ARAY currently screens at market cap $140.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ARAY and TECH stock pages for the full models.
Not investment advice.